Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Martin McCourt

OTHER INVESTOR TYPE
2 INVESTMENTS
2 PORTFOLIO
Description

Mr. Martin McCourt serves as Chairman at FreeFlow Technologies. Mr. Martin served as Chairman at Dudson. He also serves as Chairman at Learning Curve Group and Lightfoot. Mr. McCourt served as Director at Montagu Private Equity and Chairman at CliniSys Group. He is also the Board Member at Headbox Solutions. He serves as Chairman & Senior Advisor at VentureFounders. Martin has spent over 35 years working at the heart of British-based manufacturing, design and marketing for quality brands such as Dyson, Mars, Duracell, Toshiba and Pelikan Martin was the CEO of Dyson for 15 years, the ideas to market-leading consumer products maker. As CEO, he devised and implemented a strategy that transformed the company from a single product, single market producer into one where 80% of the business comes from 52 markets around the world. In that time he increased UK skilled jobs, grew profits tenfold and enabled James Dyson to keep on inventing. In 2011 Dyson hit £1bn revenue for the first time. Martin was directly responsible for the establishment of Dyson subsidiaries in the USA, Japan, Switzerland, Austria and Germany. In total he took Dyson into over 50 markets, achieving market leadership in the majority including the USA. Martin's previous experience was in sales and marketing with successful global companies Mars, Duracell, Toshiba and Pelikan. In 2010 Martin was named Orange Business Leader of the Year. Martin was Chairman of CAP, a market-leading provider of vehicle valuation data, new vehicle information and business solutions to the automotive industry, from 2012 until its sale in 2014. He is currently Chairman of CliniSys Group (CliniSys), the market leading supplier in Europe of clinical laboratory information management systems (LIMS), D.O.R.C (Dutch Ophthalmic Research Center) a prominent provider of innovative instruments and equipment for ophthalmic surgery and Equatex, the foremost supplier of international employee and executive compensation plan services.

Primary Investor Type
Angel (individual)
Primary Office
  • 1 West Regent Street
  • Glasgow G2 1RW
  • Scotland, United Kingdom

+44 07891 000000

Martin McCourt Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Tech Will Save Us 27-Nov-2018 Later Stage VC 00.000 Electronics (B2C) Generating Revenue 000000 0000000
0000000 09-Feb-2017 0000 00000 00.000 Social/Platform Software Generating Revenue 000000 0000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Martin McCourt’s full profile, request a free trial.

Martin McCourt Team (1)

Name Title Deals Funds Boards Office Contact
Info
Martin McCourt Angel Investor 0 0 Glasgow, United Kingdom